ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 2604

$444K Total Retail Price of All Prescriptions

Rank: 288 out of 2604

312 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

43% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,885 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 782 243 S3 1 1
SIMVASTATIN 416 237 2 2
OMEPRAZOLE 408 262 3 5
METFORMIN HCL 321 143 4 7
WARFARIN SODIUM 302 286 5 13
AMLODIPINE BESYLATE 288 218 6 6
LEVOTHYROXINE SODIUM 262 167 7 4
LISINOPRIL 239 112 8 3
METOPROLOL TARTRATE 229 177 9 9
FUROSEMIDE 216 166 10 8
CLONIDINE HCL 154 92 11 56
CYCLOBENZAPRINE HCL 149 36 R 12 43
PROAIR HFA 138 30 13 27
ALENDRONATE SODIUM 132 82 14 29
TRAMADOL HCL 131 72 15 15
MIRTAZAPINE 124 106 16 52
LANTUS 115 89 17 40
POTASSIUM CHLORIDE 109 62 18 16
RANITIDINE HCL 108 15 19 25
GABAPENTIN 103 50 20 12
LOSARTAN POTASSIUM 102 53 21 20
PANTOPRAZOLE SODIUM 101 56 22 64
LOVASTATIN 93 27 23 24
CITALOPRAM HBR 91 54 24 18
ISOSORBIDE MONONITRATE ER 91 57 24 38
TRAZODONE HCL 88 24 26 46
HYDRALAZINE HCL 88 65 26 85
AMLODIPINE BESYLATE-BENAZEPRIL 85 33 28 95
CLOPIDOGREL 83 67 29 39
METOCLOPRAMIDE HCL 80 56 30 181
ATENOLOL 77 33 31 11
MELOXICAM 75 32 32 36
SERTRALINE HCL 74 27 33 23
VENTOLIN HFA 71 42 34 63
LACTULOSE 71 29 34 108
DONEPEZIL HCL 71 70 34 28
HYDROCORTISONE 70 14 37 161
LYRICA 67 15 38 79
PHENYTOIN SODIUM EXTENDED 66 0 39 135
CARVEDILOL 66 35 39 26
SILVER SULFADIAZINE 65 0 41 313
ZETIA 64 51 42 94
ALBUTEROL SULFATE 63 55 43 93
PLAVIX 62 50 44 75
NAMENDA 61 61 45 37
METOPROLOL SUCCINATE 60 0 46 17
DIGOXIN 59 51 47 71
FENOFIBRATE 58 27 48 69
ADVAIR DISKUS 58 37 48 41
PROPRANOLOL HCL 57 0 50 154
FLUTICASONE PROPIONATE 57 20 50 31
KIONEX 51 51 52 491
SPIRIVA 50 22 53 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.